QIAGEN NV
(NYSE : QGEN)

( )
QGEN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp.
0.53%149.630.7%$1822.06m
MDTMedtronic Plc
0.62%111.730.6%$500.02m
TMOThermo Fisher Scientific, Inc.
0.08%317.351.0%$366.52m
ABTAbbott Laboratories
0.44%84.930.8%$361.79m
ISRGIntuitive Surgical, Inc.
-0.10%574.792.4%$316.75m
BDXBecton, Dickinson & Co.
1.50%261.111.1%$299.11m
EWEdwards Lifesciences Corp.
0.53%230.381.2%$287.40m
SYKStryker Corp.
-0.06%198.011.3%$258.78m
BSXBoston Scientific Corp.
-0.43%43.821.1%$250.38m
BAXBaxter International, Inc.
0.88%83.011.8%$206.13m
DXCMDexCom, Inc.
-1.47%212.368.3%$204.63m
PODDInsulet Corp.
1.12%180.196.7%$160.58m
MTDMettler-Toledo International, Inc.
1.16%762.935.4%$158.47m
ALGNAlign Technology, Inc.
0.58%275.236.4%$146.22m
HOLXHologic, Inc.
0.77%52.601.7%$145.35m

Company Profile

QIAGEN NV is a holding company, which engages in the provision of sample and assay technology to transform biological samples into valuable molecular insights. It offers bioinformatics, molecular diagnostics, next-gen sequencing, and genomic services. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996 and is headquartered in Venlo, the Netherlands.